Fundraising FoxMethuselah Foundation
FoundationSpringfield · Seed · 15 people tracked
Find your way into Methuselah Foundation
Sign up to find every way you can get introduced to Methuselah Foundation
- Your email: who you already know at Methuselah Foundation, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Methuselah Foundation team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Methuselah Foundation pursues a mission-first approach to advancing healthy human longevity, supporting research and companies in regenerative medicine, biotech, and age-related disease. Through its Methuselah Fund subsidiary it makes strategic investments in startups developing technology to extend healthy lifespan, offering an alternative to traditional venture capital that it argues pressures young companies toward premature profitability and away from their longevity mission. The foundation also runs prize challenges and partnerships with institutions such as NASA, the ISS National Laboratory, and leading medical research centers to accelerate breakthroughs in tissue engineering, organ preservation, and age-related disease treatment.
Source: firm website, verified Oct 2, 2026.
Team · 15 people
from the firm's websiteWhat they invest in
from 4 of 11 portfolio companiesBiotech ×4Deep Tech ×3Healthtech ×3Medical Devices ×3New Materials ×1
HQs:United States×4
Investments · 11 tracked
founders shown can be your intro path
OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity.
BiotechDeep TechHealthtechSeattle, US
Matt Scholz(Executive Officer, Director)John Lewis(Executive Officer, Director)inGary Hudson(Director)in
Co-investorsHelios CapitalChainFund CapitalInvesco
Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol.
BiotechHealthtechMedical DevicesSyracuse, US
Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)
BoardKelsey Moody(Director)
Co-investorsquadraScope Venture FundThynk Capital
Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Jordan Miller(Co-Founder and President)inBagrat Grigoryan(Co-Founder, COO)in
Co-investorsGoAhead VenturesHarmonix FundHelios CapitalJoyance PartnersJude GomilaSand Hill Angels+21 more
X-Therma develops a proprietary peptoid-based technology that inhibits ice crystal formation to enable long-term sub-zero preservation and transport of cells, tissues, organs, and other biologics.
BiotechDeep TechMedical DevicesNew MaterialsRichmond, US
Xiaoxi Wei(Founder & CEO)inMark Kline(Executive Officer, Director)inJohannes Weggemann(Director)
Co-investorsAurum Venture PartnersDellin InvestmentsLIFTTPortfoliaVU Venture PartnersZen11 Holding
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Leucadia TherapeuticsMethuselah FundOisin TechnologiesOrganovoSilverstone SolutionsTurn BioViscient Biosciences
Exits · 1
1 acquisitionsVolumetricacq. by 3D Systems
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Methuselah Foundation made?
- Methuselah Foundation has 11 tracked investments, 1 of which have exited.
- What stage does Methuselah Foundation invest at?
- Methuselah Foundation invests at the Seed stage.
- What sectors does Methuselah Foundation focus on?
- Methuselah Foundation focuses on Biotech, Healthtech, Impact & Social Good, Longevity, Medical Devices.
- Where is Methuselah Foundation located?
- Methuselah Foundation is headquartered in Springfield, US.